94
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Organic Cation Transporters in Human Nasal Primary Culture: Expression and Functional Activity

, , , , , & show all
Pages 439-451 | Published online: 04 Apr 2013

References

  • Goadsby PJ , YatesR. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Headache46, 138–149 (2006).
  • Turker S , OzerY. Nasal route and drug delivery systems. Pharm. World Sci.26(3), 137–142 (2004).
  • Vyas TK , ShahiwalaA, MaratheSet al. Intranasal drug delivery for brain targeting. Curr. Drug Deliv. 2(2), 165–175 (2005).
  • Alpar HO , AtuahKN, BramwellVW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev.57(3), 411–430 (2005).
  • Davis SS , IllumL. Absorption enhancers for nasal drug delivery. Clin. Pharmacokinet.42(13), 1107–1128 (2003).
  • Tertti K , EkbladU, HeikkinenTet al. The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. Eur. J. Pharm. Sci. 39(1–3), 76–81 (2010).
  • Huber-Ruano I , Pastor-AngladaM. Transport of nucleoside analogs across the plasma membrane: a clue to understanding drug-induced cytotoxicity. Curr. Drug Metab.10(4), 347–358 (2009).
  • Shen S , ZhangW. ABC transporters and drug efflux at the blood-brain barrier. Rev. Neurosci.21(1), 29–53 (2010).
  • Brandsch M , KnütterI, Bosse-DoeneckeE. Pharmaceutical and pharmacological importance of peptide transporters. J. Pharm. Pharmacol.60(5), 543–585 (2008).
  • Sai Y , TsujiA. Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov. Today.9(16), 712–720 (2004).
  • Oswald S , GrubeM, SiegmundWet al. Transporter-mediated uptake into cellular compartments. Xenobiotica 37(10–11), 1171–1195 (2007).
  • Koepsell H , LipsK, VolkC. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res.24(7), 1227–1251 (2007).
  • Wright EM , HirayamaBA, LooDF. Active sugar transport in health and disease. J. Intern. Med.261(1), 32–43 (2007).
  • Salomon JJ , EhrhardtC. Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. Ther. Deliv.3(6), 735–747.
  • Koepsell H , SchmittBM, GorboulevV. Organic cation transporters. Rev. Physiol. Biochem. Pharmacol.150, 36–90 (2003).
  • Zhang L , BrettCM, GiacominiKM. Role of organic cation transporters in drug absorption and elimination. Annu. Rev. Pharmacol. Toxicol.38, 431–460 (1998).
  • Chemuturi NV , HaraldssonJE, PrisinzanoT, DonovanM. Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa. Life Sci.79(14), 1391–1398 (2006).
  • Thiebaud N , MenetrierF, BelloirCet al. Expression and differential localization of xenobiotic transporters in the rat olfactory neuro-epithelium. Neurosci. Lett. 505(2), 180–185(2011).
  • Genter MB , KrishanM, AugustineLMet al. Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb. Drug Metab. Dispos. 38(10), 1644–1647 (2010).
  • Agu R , MacDonaldC, CowleyEet al. Differential expression of organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug delivery studies. Int. J. Pharm. 406(1–2), 49–54(2011).
  • Rohlicek V , UllrichKJ. Simple device for continuous measurement of fluorescent anions and cations in the rat kidney in situ. Ren. Physiol. Biochem.17(2), 57–61 (1994).
  • Stachon A , SchlatterE, HohageH. Dynamic monitoring of organic cation transport processes by fluorescence measurements in LLC-PK1 cells. Cell Physiol. Biochem.6, 72–81 (1996).
  • Agu RU , JorissenM, WillemsTet al. In vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies. J. Pharm. Pharmacol.53(11), 1447–1456 (2001).
  • Venkatesh G , RamanathanS, NairNKet al. Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatography/UV detection. Biomed. Chromatogr. 21(5), 484–490 (2007).
  • Cereijido M , RuizO, González-MariscalLet al. In: Biological Barriers to Protein Delivery. Audus KL, Raub TL (Eds). Plenum Press, NY, USA, 3–21 (1993).
  • Monte JC , NagleMA, EralySAet al. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem. Biophys. Res. Comm. 323(2), 429–436 (2004).
  • Bosquillon C . Drug transporters in the lung – do they play a role in the biopharmaceutics of inhaled drugs? J. Pharm. Sci.99(5), 2240–2255 (2010).
  • Bleasby K , CastleJC, RobertsCJet al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36(10–11), 963–988 (2006).
  • Horvath G , SchmidN, FragosoMAet al. Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am. J. Respir. Cell Mol. Biol. 36(1), 53–60 (2007).
  • Ehrhardt C , KneuerC, BiesCet al. Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm. Pharmacol. Ther. 18(3), 165–170(2005).
  • Salomon JJ , EndterS, TachonGet al. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. Eur. J. Pharm. Biopharm. 81(2), 351–359 (2012).
  • Mukherjee M , PritchardDI, BosquillonC. Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. Int. J. Pharm.426(1–2), 7–14 (2012).
  • Shao D , MassoudE, ClarkeDet al. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro. Int.J. Pharm. 441(1–2), 334–342 (2013).
  • Boess F , KamberM, RomerSet al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared with the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73(2), 386–402 (2003).
  • Macdonald C , ShaoD, OliAet al. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies. J. Drug Target. 21(1), 97–106 (2013).
  • Martel F , GründemannD, CalhauCet al. 2001. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch. Pharmacol. 363(1), 40–49 (2001).
  • Omote H , HiasaM, MatsumotoTet al. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol. Sci. 27(11), 587–593 (2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.